Background: Diabetes mellitus (DM) is one of the most frequent chronic diseases worldwide and is characterized by absolute or relative deficiencies in insulin secretion and/or insulin action associated with chronic hyperglycemia.
diabetes. About 80% lives in low-and middle-income countries. If these trends continue, by 2035, some 592 million people, or one adult in 10, will have diabetes. This equates to approximately three new cases every 10 seconds or almost 10 million per year. The largest increases will take place in the regions where developing economies are predominant. [2] Hyperglycemia generates reactive oxygen species (ROS), which in turn cause damage to the cells in many ways. Damage to the cells ultimately results in secondary complications in DM. [3] Oxidative stress plays a pivotal role in cellular injury from hyperglycemia. High glucose level can stimulate free radical production. Weak defense system of the body becomes unable to counteract the enhanced ROS generation and as a result condition of imbalance between ROS and their protection occurs, which leads to domination of the condition called oxidative stress. [4] Introduction Diabetes mellitus (DM) is a group of metabolic disease characterized by hyperglycemia resulting from a defect in insulin secretion, insulin action, or both. [1] Some 382 million people worldwide, or 8.3% of adults, are estimated to have Malondialdehyde (MDA) is an organic compound with the formula CH 2 (CHO) 2 . This reactive species occurs naturally and is a marker for oxidative stress. ROS degrade polyunsaturated lipids present on cell membrane forming MDA. This aldehyde product is used as a biomarker to measure the level of oxidative stress in an organism. [4] Glycated hemoglobin (HbA1c) is a form of hemoglobin used primarily to identify the average plasma glucose concentration over a prolonged period. It is formed in a nonenzymatic pathway by normal exposure of hemoglobin to high plasma levels of glucose. Glycation of hemoglobin had been associated with cardiovascular diseases, nephropathy, and retinopathy in DM. [5] HbA1c is effective in monitoring long-term glucose control in people with DM. [6] It has been shown that elevated HbA1c is associated with an increased risk of complications in patients with type 2 DM and that lowering of HbA1c reduces such risk. Thus, HbA1c serves as a surrogate for the risk of microvascular and macrovascular complications, and these results firmly establish HbA1c as a useful measure of long-term glycemic control. [7] This study was conducted with an objective to evaluate oxidative stress in patients of DM and correlate it with glycemic control. 
Materials and Methods

Subjects
A total of 90 subjects of both sex groups, aged between 45-60 years were enrolled for this study. Of the 90 subjects, 60 were type 2 diabetic patients and 30 were healthy nondiabetic individuals. Healthy nondiabetic individuals serve as controls for this study and were selected from general population of the same region. Participants were informed about the study. Informed consent was taken from each subject.
Exclusion Criteria
The individuals having hepatic disease, cardiovascular disease, any chronic or acute inflammatory illness, all types of cancer, pulmonary tuberculosis, addiction to alcohol, who smoke, and having prolonged illness were excluded from the study.
Glycemic Status
Glycemic status was categorized as good glycemic control if HbA1c <7% and poor glycemic control if HbA1c ≥7%.
Collection of Blood Sample
About 5 mL of blood was drawn after an overnight fast under aseptic precautions from clinically diagnosed type 2 DM patients and controls, and divided into 2 tubes, marked as 1 and 2. 1. Test tube 1 contains 3 mL of blood with no anticoagulant and blood was allowed to clot and serum was separated. Serum was used for measurement of blood sugar and MDA. 2. Test tube 2 contains 2mL of blood, with Ethylene diamine tetra acetic acid (EDTA) as an anticoagulant, which was used for estimation of HbA1c.
Parameters Measured
The following parameters were measured in this study: 1. serum fasting blood sugar (FBS); 2. serum MDA; 3. HbA1c.
Serum FBS was measured by GOD-POD method with the help of CPC TurboChem100, a fully automatic analyzer. Serum MDA was measured by the method described by Kei Satoh. [8] HbA1c was measured by turbidimetric immunoassay with the help of CPC TurboChem100.
Statistical Analysis
Results were statistically analyzed by "GraphPad QuickCalcs t-test calculator." Student's t-test was used to assess the significance of difference between the groups. All results were presented as mean ± standard deviation (SD). A p-value of less than 0.05 was considered significant.
Result
Based on HbA1c level, of the 60 subjects with diabetes, 30 patients had poor glycemic control whereas remaining 30 had good glycemic control.
Diabetic patients with poor glycemic control have increase in the levels of MDA and HbA1c as compared with nondiabetic control and were statistically highly significant (p < 0.0001). The MDA level in diabetic patients with good glycemic control was increased as compared with nondiabetic control and was statistically significant (p = 0.0186) whereas the differences of HbA1c level between diabetic patients with good glycemic control and nondiabetic control were statistically insignificant (p = 0.3297). The HbA1c and MDA levels in diabetic patients with poor glycemic control were increased compared with diabetic patients with good glycemic control and the differences were statistically highly significant (p < 0.0001). In all the studied groups, MDA was positively correlated with HbA1c.
Discussion
There has been considerable interest in the concept that the uncontrolled lipid peroxidation is a key contributing factor in the pathophysiology of coronary artery disease, especially in type 2 diabetes. Lipid peroxidation eventually is a sequence of the injury caused by ROS. Free radical damages can accumulate over time and may thereby contribute to cell injury and development of human diseases. Free radicals have been implicated in the development of several diseases including atherosclerosis, diabetes, hypertension, and obesity. [9, 10] In this study, type 2 diabetic patients with poor glycemic control had significantly higher levels of MDA and HbA1c as compared with nondiabetic control, which is in agreement with the study done by Ikekpeazu et al. [11] In this study, HbA1c is used as an index of metabolic control. The increased HbA1c levels reflect the poor metabolic control of diabetic patients. This study also showed that type 2 diabetic patients with good glycemic control had slightly increased levels of HbA1c and MDA compared with nondiabetic control but the differences were statistically insignificant. Our study is in contrast with the study done by Ikekpeazu et al., who showed that the MDA levels were significantly increased in diabetic patients with good glycemic control as compared with nondiabetic control. [11] The result showed that MDA was positively correlated with HbA1c in diabetic patients. This was in agreement with some previous studies. [6, 11] It is known that hyperglycemia leads to glycosylation of proteins such as Hb, which could also lead to the formation of free radicals because of auto-oxidation of Amadori products. [12] This study supports the fact that there are increased levels of FBS and MDA in type 2 DM patients compared with nondiabetic controls and the oxidative stress that is measured as MDA is strictly influenced by glycemic control.
Conclusion
In our study, we concluded that there is a positive correlation of MDA with HbA1c in diabetic patients. So, the study suggests that MDA and antioxidants should be measured as markers of lipid peroxidation along with routine parameters of disease, and antioxidants should be incorporated in medication given to diabetic patients so that it can counterbalance the oxidative stress produced during diabetes. However, further studies with adequate sample size are needed to validate this suggestion. 
